Significant expansion of an early effector with stem cell-like progenitor properties (PD-1- / Tim3-) CD8 T cells and CD4 T cells in immune infiltrates of tumors originated from HVEM deficient leukemia cells. This evidence concerns the gene HAVCR2 and leukemia.